The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Reata Pharmaceuticals, Inc(NASDAQ:RETA) 
Reata Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. The company is developing Phase III clinical trial programs,...
Website: http://www.reatapharma.com
Founded: 2002
Full Time Employees: 220
Sector: Healthcare
Industry: Biotechnology
Reata Pharmaceuticals Days Payable Outstanding ttm (DPO)
Reata Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Reata Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Reata Pharmaceuticals Op Cashflow Per Share ttm
Reata Pharmaceuticals Free Cashflow Per Share ttm
Reata Pharmaceuticals Cash Per Share ttm
Reata Pharmaceuticals P/S ratio ttm
Reata Pharmaceuticals (GAAP) P/E ratio ttm
Reata Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.